Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
·MeSH: Hypophosphatemic Rickets, Autosomal Recessive, 1
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| inz-701 | Inozyme Pharma, Inc. (INZY) |
Frequently asked questions
How many drugs are in development for Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency?
BioSniper tracks 1 drug in development for Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency across 1 company.
How many clinical trials target Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency?
There are 2 clinical trials targeting Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency tracked by BioSniper.
Deep-dive into Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis